Lorenzo Moroni receives ERC Proof of Concept grant
Lorenzo Moroni, interim scientific director of MERLN, is the lucky recipient of an ERC Proof of Concept grant for his proposal entitled “The hydrocup: a hollow electrospun scaffold for in vivo cell-laden hydrogel delivery”.
This grant is based on the research performed with a previous ERC starting grant in which Lorenzo’s group showed that adult stem cells encapsulated inside electrospun “hydrocups” remained viable for 28 days in vitro and released functional cytokines similar to hMSCs in hydrogels alone. In addition, the hydrocups remained intact and fixed in place for 6 weeks after subcutaneous implantation in rats. This is very promising since secreted cytokines can have positive effects such as immunomodulation, angiogenesis and tissue regeneration.
In this ERC proof of concept proposal, they will further study the hydrocup as a device for a wide variety of cell-based cytokine secretion or drug-laden hydrogel applications. Of special interest is the cardiac regeneration market where stem cell based therapies have so far suffered from low viability of cells after injection. Following a market analysis study of competitors in the cell therapy field, they will propose an initial business plan for seeking further investments to create a spin-off company at the end of the grant.
Also read
-
The Societal Impact Project
The Societal Impact Project stimulates students’ autonomous motivation to work on societal relevant problems. One of the topics this year is vaping.
-
Vaccine promotion policies for COVID-19
Two researchers from Maastricht University play a key role in translating research into vaccine policy recommendations for COVID-19: Timo Clemens, Associate Professor health policy and governance, and Inge van der Putten, Assistant Professor at the department of Health Services Research.
-
Caroline Coeckelbergh - never too old for sun protection
Despite widespread awareness campaigns and well-known prevention strategies, the number of skin cancer cases continues to rise. It is now the most common form of cancer in the Netherlands, particularly among people over the age of 65. According to Caroline Coeckelbergh, alumna of the master’s...
